Related Experiment Video
Updated: Oct 10, 2025

Counting Proteins in Single Cells with Addressable Droplet Microarrays
Published on: July 6, 2018
p53, p21, and cyclin d1 protein expression patterns in patients with breast cancer
Marwa Mohammed Ali Jassim1, Khetam Habeeb Rasool2, Majid Mohammed Mahmood2
1Department of Basic Science, College of Dentistry, Al-Muthanna University, Al-Muthanna, Iraq.
Background And Aim:
The mutation in the wild-type tumor suppressor gene p53 is the most common genetic change in human tumors. In addition, the normal function of p21, which is both antiproliferative and an inhibitor of the cell cycle, is disrupted in some types of cancer. Meanwhile, cyclin D1 is a member of the cyclin protein family that is involved in regulating cell cycle progression. This study aimed to assess the expressions of the cell cycle inhibitory proteins p21, cyclin D1, and tumor suppressor gene p53, as well as their influence on the expressed histopathological changes in breast cancer tissues.
Materials And Methods:
Overall, 40 breast tissue specimens were investigated in this study, 30 of which were cancerous, while 10 were healthy tissues. p53, p21, and cyclin D1 expression patterns were detected using an immunohistochemistry (IHC) system.
Results:
The IHC reactions for p53 were positively observed in 27/30 (90%) cancerous tissues, compared with 2/10 (20%) normal breast tissues. For p21, reactions were observed in 28/30 (93.33%) cancerous tissues and 3/10 (30%) control tissues. For cyclin D1, reactions were observed in 25/30 (83.33%) cancerous tissues and 1/10 (10%) control tissues. The differences between the breast cancer tissues and the control tissues were statistically highly significant (p<0.01).
Conclusion:
The high expression rates of p21, cyclin D1, and p53 in malignant breast cancer cells with little or no regulatory role might imply mutational events in these proteins operating in concert with a variety of other genetic mutations in these tissues, which may play a molecular role in the development and/or progression of breast carcinogenesis.
Insights
High expression of cell cycle regulators p21, cyclin D1, and tumor suppressor p53 in breast cancer suggests coordinated mutations contributing to carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tumor suppressor gene p53 is frequently mutated in human cancers.
- p21 is an antiproliferative cell cycle inhibitor, and cyclin D1 regulates cell cycle progression.
- Disruptions in these proteins are implicated in various cancer types.
Purpose of the Study:
- To evaluate the expression of p21, cyclin D1, and p53 in breast cancer tissues.
- To investigate the correlation between these protein expressions and histopathological changes in breast cancer.
Main Methods:
- Immunohistochemistry (IHC) was used to detect p53, p21, and cyclin D1 expression.
- 40 breast tissue samples were analyzed: 30 cancerous and 10 healthy.
Main Results:
- Significantly higher expression of p53 (90%), p21 (93.33%), and cyclin D1 (83.33%) was observed in cancerous tissues compared to normal tissues (p<0.01).
- p53 was detected in 90% of tumors, p21 in 93.33%, and cyclin D1 in 83.33%.
Conclusions:
- Elevated p21, cyclin D1, and p53 in malignant breast cells may indicate their altered regulatory roles.
- These findings suggest that mutations in these proteins, alongside other genetic alterations, could contribute to breast cancer development and progression.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Positive Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle

